|

DSP-0390 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Early 1: 1Phase 1: 1

Top Sponsors

  • Washington University School of Medicine2

Indications

  • Cancer2
  • IDH Mutation1
  • Small Cell Lung Cancer Extensive Stage1
  • Grade II Glioma1
  • Glioma, Malignant1

St Louis, Missouri2 trials

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

Washington University School of Medicine

Phase 1
Window of Opportunity Study of DSP-0390 in Gliomas

Washington University School of Medicine

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.